EMA Recommends Granting a Marketing Authorisation for Nirogacestat By Ogkologos - July 3, 2025 237 0 Facebook Twitter Google+ Pinterest WhatsApp It is intended for the treatment of adult patients with progressing desmoid tumours Source RELATED ARTICLESMORE FROM AUTHOR Induction ICI Combination Followed by CRT Is An Effective Bladder-Sparing Treatment in Patients with MIBC and Response Can Be Monitored by ctDNA New Survey Highlights the Role of Clinical Practice Guidelines to Improve Care for Patients with Rare Cancers FDA Grants Traditional Approval to Encorafenib for mCRC with a BRAF V600E Mutation MOST POPULAR FDA Approves Mirdametinib for Adult and Paediatric Patients with NF1 Who... March 20, 2025 New Radiation Therapy Won’t Leave Breast Cancer Patients with Unwanted Tattoo... September 13, 2019 For Children with Neuroblastoma, Trial Results Highlight Continued Evolution of Treatment September 23, 2019 Experimental CAR T-Cell Therapy Shrinks Tumors in Children with Deadly Brain... January 2, 2025 Load more HOT NEWS Penn State Researchers Working on Amazon Alexa Skill for Metastatic Breast... Breast Cancer Survivors in Happy Romantic Relationships Are Healthier, Study Says Embryos in the Womb Can Get Gene Mutations That Lead to... The IGCCCG Update Model Allows Improved and More Granular Individual Prognostic...
